| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/08/2008 | US20080108600 Polycyclic Pyridines as Potassium Ion Channel Modulators |
| 05/08/2008 | US20080108594 Antithrombotic Ethers |
| 05/08/2008 | US20080107608 selective modulators of corticotropin -releasing factor (CRF) receptors, central and periphereal nervous system disorders; antidepressant, anxiolytic agent; stress, cardiovascular disorders, and eating disorders; probes for the localization of CRF receptors |
| 05/08/2008 | CA2668006A1 Substituted pyridin-3-yl amides as 1.beta.hsd1 inhibitors |
| 05/08/2008 | CA2666138A1 Kinase inhibitors |
| 05/08/2008 | CA2664430A1 Immunochemically equivalent hiv drug analogs |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1917262A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 05/07/2008 | EP1917244A2 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 05/07/2008 | EP1917240A1 Immunosuppressant compounds and compositions |
| 05/07/2008 | EP1917238A2 Sulfonamides |
| 05/07/2008 | EP1917233A1 Chemical compounds |
| 05/07/2008 | EP1558606A4 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 05/07/2008 | EP1483285B1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1411984B1 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 05/07/2008 | EP1404643A4 Cleavable surfactants and methods of use thereof |
| 05/07/2008 | CN101172955A Diamine anti-cancer medicine |
| 05/07/2008 | CN100386691C Electrooptic device containing ion liquid, electrooptic vehicle mirror, and electrolytes therefor |
| 05/07/2008 | CN100386317C Production of nicotine acid and catalyst therefor |
| 05/06/2008 | US7368585 Protected trihydroxyisoalkatrienyltriphenylphosphonium halides for proparing polyhydroxylactones; acid stable protecting groups include p-methoxybenzyl and tert-butyldimethylsilyl. |
| 05/06/2008 | US7368572 Anticancer agents |
| 05/06/2008 | US7368479 Alpha-sulfonylamino-acetonitriles |
| 05/06/2008 | US7368473 Paclitaxel enhancer compounds |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2377803C Phenyl sulfamate derivatives |
| 05/06/2008 | CA2244979C Proton conductor in liquid form |
| 05/02/2008 | WO2008051017A1 A cleavage agent selectively acting on soluble assembly of amyloidogenic peptide or protein |
| 05/02/2008 | WO2008050858A1 Amide compound, salt thereof, and biofilm remover using them |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008050168A1 New sulfonamide derivatives as bradykinin antagonists |
| 05/02/2008 | WO2008050167A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/02/2008 | WO2008049729A1 Non-steroidal brassinosteroid mimetic |
| 05/02/2008 | WO2008049595A1 Trypsin-like serine protease inhibitors, and their preparation and use |
| 05/02/2008 | WO2008002676A3 Biaryl compositions and methods for modulating a kinase cascade |
| 05/02/2008 | CA2667507A1 Trypsin-like serine protease inhibitors, and their preparation and use |
| 05/02/2008 | CA2666124A1 Non-steroidal brassinosteroid mimetic |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103135 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 04/30/2008 | EP1916239A1 Pyridone compound |
| 04/30/2008 | EP1916236A1 Amide derivative, pesticide containing such compound and use thereof |
| 04/30/2008 | EP1915386A1 Metal complex |
| 04/30/2008 | EP1915355A1 Therapeutic agents |
| 04/30/2008 | EP1915352A1 Compounds for the treatment of alzheimer's disease |
| 04/30/2008 | EP1915344A1 Cyanopyridine pesticides |
| 04/30/2008 | EP1915343A1 Method for producing heteroaromatic alcohols |
| 04/30/2008 | EP1915339A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 04/30/2008 | EP1915338A2 Androgen modulators |
| 04/30/2008 | EP1713791B1 5-fluoro- and chloro-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5 |
| 04/30/2008 | EP1506168B1 Gelling agents |
| 04/30/2008 | CN101171717A Polymer ionic electrolytes |
| 04/30/2008 | CN101171231A Diacylglycerol acyltransferase inhibitors |
| 04/30/2008 | CN101168528A Method for synthesizing 3-aminopyrrolidine and dihydrochloride thereof |
| 04/30/2008 | CN100384821C Cetp activity inhibitors |
| 04/29/2008 | US7365204 Process for the production of pyridine and picolines |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365091 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX |
| 04/29/2008 | US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 04/29/2008 | US7365076 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/29/2008 | US7365075 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; potentiation; diabetes and obesity; 2-(4-{4-[1-(6-chloro-pyridin-3-yl)cyclopropylmethyl]-2-(R)-methyl-piperazine-1-sulfonyl}phenyl)-1,1,1-trifluoro-propan-2-ol |
| 04/29/2008 | US7365074 Pyridazine, pyrimidine and pyrazine ethyne compounds |
| 04/29/2008 | US7365072 Inhibitors of p38 |
| 04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | US7365060 Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment |
| 04/29/2008 | US7365042 4-trifluoromethyl-pyridine-3-sulfonic acid prop-2-ynylamide; 4-trifluoromethyl-pyridine-3-sulfonic acid cyanomethylamide |
| 04/29/2008 | CA2425494C Process for making 3-amino-2-chloro-4-methylpyridine |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/24/2008 | WO2008048987A1 Processes suitable for producing macromolecular antioxidant compositions |
| 04/24/2008 | WO2008047839A1 5-ht1a receptor agonist |
| 04/24/2008 | WO2008047769A1 Glucose metabolism ameliorating agent |
| 04/24/2008 | WO2008047201A2 Solid dispersion comprising a poorly water soluble drug |
| 04/24/2008 | WO2008046838A2 N- (3-pyridin-2-ylpropyl) benzamide derivatives as fungicides |
| 04/24/2008 | WO2008046463A1 Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof |
| 04/24/2008 | WO2007142929A3 Novel pde4 inhibitors |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080097099 Insecticides; for human or veterinary medicine; preparing heterocyclic amide and imine derivatives |
| 04/24/2008 | US20080096960 4-amino-3-(4-chlorophenyl)butanoic acid; prodrugs of baclofen and baclofen analogs; gamma aminobutanoic acid agonist; drug, nicotine, and narcotic abuse; antitussive, antiemetic agent; cough, nausea, vomiting; oral administration; sustained release dosage form |
| 04/24/2008 | US20080096937 For example, 2-{4-[(2-chloro-benzyl)-ethyl-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; the compounds bind to and selectively activate LXR alpha and LXR beta; used to treat diseases such as atherosclerosis and diabetes |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096934 N-[4-((S)-2-Propylamino-propyl)-phenyl]-4-trifluoromethoxy-benzenesulfonamide; Dipropyl-{2-[4-(4-trifluoromethoxy-benzenesulfonylmethyl)-phenyl]-ethyl}-dipropyl-amine salt, psychological, nervous system disorders such as schizophernia, bipolar, dyskinesias, tourette syndrome, depression, sleep disorder |
| 04/24/2008 | US20080096930 1-(2-hydroxy-3-methyl-4-{4-[4-(1H-tetrazol-5-yl)-pyridin-2-yloxy]-benzyloxy}-phenyl)-ethanone; 6-(3-((4-acetyl-3-hydroxy-2-propylphenoxy)methyl)phenylthio)isonicotinic acid; 1-(2-hydroxy-4-{3-[4-(2H-tetrazol-5-yl)-pyridin-2-yloxy]-benzyloxy}-3-trifluoromethyl-phenyl)-ethanone; treatment of migriane |
| 04/24/2008 | US20080096922 N-{[cis-1-(3-methoxyphenyl)-4-(piperidin-4-ylamino)-cyclohexyl]methyl}sulfamide diHCL; tert-butyl [({[cis-4-[(biphenyl-4-ylmethyl)amino]-1-(3-methoxyphenyl)cyclohexyl]methyl}amino)sulfonyl]carbamate; for potentiating expression of low density lipoprotein recepotr; arteriosclerosis; hyperlipidemia |
| 04/24/2008 | US20080096908 Nitrate derivatives of atorvastatin with improved pharmacological activity and enhanced tolerability; coronary syndromes, neurodegenerative disorders, and for reducing cholesterol levels; antiinflammatory, antithrombotic and antiplatelet activity; fluvastatin 4-(nitrooxy)butyl ester |
| 04/24/2008 | US20080096894 Anti-Bacterial Compounds |
| 04/24/2008 | US20080096892 C-Kit Modulators And Methods Of Use |
| 04/24/2008 | US20080096889 Histone Deacetylases Inhibitors |
| 04/24/2008 | US20080096876 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 04/24/2008 | US20080096875 Hepatitis C virus infection; thiourea-substituted dibenzofuran, fluorene, or carbazole compounds |
| 04/24/2008 | US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/24/2008 | US20080092307 Dyeing, bleaching keratinous fibers (hair); 2-[5-(N-methyl-2-pyridinylidene)-3-methyl-1-formazano]-N-methylpyridinium chloride |
| 04/24/2008 | CA2666910A1 Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use |
| 04/23/2008 | EP1914226A1 1-{4-[2-(9-anthrylmethoxy)ethyl]benzyl}-1'-methyl-4,4'-bipyridinium salts and related compounds as bifunctional compounds with an intercalating and a signal emitting unit for the detection of nucleic acids |
| 04/23/2008 | EP1914225A1 Salt molten at room temperature and display device |
| 04/23/2008 | EP1912988A1 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 04/23/2008 | EP1912947A1 Isotopically substituted pantoprazole |
| 04/23/2008 | EP1912946A1 Pyridine derivatives as dipeptedyl peptidase inhibitors |
| 04/23/2008 | EP1912497A1 Fungicidal n-[2-(haloalkoxy)phenyl]heteroarylcarboxamides |
| 04/23/2008 | EP1802578B1 3,6-substituted 5-arylamino-1h-pyidine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis |
| 04/23/2008 | EP1745006A4 Methods of 1,3-enyne preparation using copper (i) catalysts |